Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD Jul 12, 2021
COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to… Jul 5, 2021
Delic Holdings Inc. Announces Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers… Jun 25, 2021
Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related… Jun 8, 2021
What Is A Compassionate Access Trial? Numinus CSO & Co-Founder Stacey Wallin Has The Details Jun 7, 2021